The implantation of the new valve is done without the need to open the heart completely, thereby drastically reducing the ...
6d
Medical Device Network on MSNMedtronic announces two-year trial outcomes of Evolut TAVRMedtronic has announced the Small Annuli Randomized To Evolut or SAPIEN (SMART) head-to-head comparative trial’s two-year ...
The following is a summary of "Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ...
Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...
Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first implants in patients.
2 Eligible patients had an aortic valve annulus area of ≤430 mm as measured by computed tomography, and suitable anatomy for transfemoral TAVR with both an Evolut PRO/PRO+/FX or a SAPIEN 3™/3 ...
India’s transcatheter aortic valve replacement (TAVR ... especially in patients with complex anatomy, which can lead to paravalvular leaks,” Shreya Jain, Medical Devices Analyst at GlobalData ...
As people age, a buildup of calcium on the aortic valve can make it thicker and stiffer leading to aortic stenosis.
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the ... deflection through the heart anatomy in a controlled manner to avoid ...
2 Eligible patients had an aortic valve annulus area of ≤430 mm as measured by computed tomography, and suitable anatomy for transfemoral TAVR with both an Evolut PRO/PRO+/FX or a SAPIEN 3™/3 Ultra™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results